Skip to content

Evaluation the efficacy of stem cells condition medium on hair transplantation outcome

Evaluation the efficacy of mesenchymal stem cells condition medium on hair transplantation outcome

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200127046282N18
Enrollment
30
Registered
2022-06-05
Start date
2022-06-20
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hair loss. Nonscarring hair loss, unspecified

Interventions

Intervention 1: Intervention group: Two weeks after the hair transplant, 3 cc stem cells condition medium is injected subcutaneously five times every two weeks at the transplant site and sprayed a lit

Sponsors

Skin and Stem cell Research Center of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Candidate hair transplant patients Absence of internal diseases except hypothyroidism Do not take drugs that cause hair loss such as chemotherapy, psychotropic drugs, anticoagulants, cardiovascular, retinoids, antimicrobials, androgen hormones Absence of psychiatric diseases such as obsessive-compulsive disorder and trichotillomania Absence of active infection in the transplanted area Age between 18-50 years

Exclusion criteria

Exclusion criteria: Reluctance to continue cooperation Pregnancy Breastfeeding Exposure to acute and severe stress during the study Allergy to xylocaine

Design outcomes

Primary

MeasureTime frame
Hair recovery rate. Timepoint: Before treatment and six months after the last session. Method of measurement: Trichoscan.

Secondary

MeasureTime frame
Side effects. Timepoint: One week after session. Method of measurement: Questionnaire and visit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem cell Research Center of Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026